Valneva SE (VALN) Current Assets (2020 - 2026)
Valneva SE's (VALN) quarterly Current Assets came in at $235.8 million in Q1 2026, down 21.89% year-on-year from $301.9 million in Q1 2025, and down 8.96% quarter-over-quarter from $259.0 million in Q4 2025.
Valneva SE (VALN) Current Assets (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Current Assets across 7 years of filings, most recently posting $235.8 million for Q1 2026.
- Current Assets for Q1 2026 came in at $235.8 million, down 21.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $235.8 million (down 21.89% YoY), and the FY2025 annual result was $259.0 million, down 18.93% from the prior year.
- Current Assets came in at $235.8 million for Q1 2026 at Valneva SE, down from $259.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $611.7 million in Q1 2022 to a low of $235.8 million in Q1 2026.
- The 5-year median for Current Assets is $332.7 million (2024), against an average of $364.3 million.
- Across the five-year window, Current Assets plunged 35.35% in 2022 and increased 12.99% in 2024, its largest moves.
- Valneva SE's Current Assets stood at $433.3 million in 2022, then sank by 34.73% to $282.8 million in 2023, then grew by 12.99% to $319.5 million in 2024, then decreased by 18.93% to $259.0 million in 2025, then retreated by 8.96% to $235.8 million in 2026.
- The last three Current Assets figures came in at $235.8 million (Q1 2026), $259.0 million (Q4 2025), and $313.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 235.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.83 Mn |
| Dec 31, 2025 | 259.05 Mn |
| Sep 30, 2025 | 313.69 Mn |
| Jun 30, 2025 | 322.29 Mn |
| Mar 31, 2025 | 301.94 Mn |
| Dec 31, 2024 | 319.52 Mn |
| Sep 30, 2024 | 333.43 Mn |
| Jun 30, 2024 | 289.85 Mn |
| Mar 31, 2024 | 332.69 Mn |
| Dec 31, 2023 | 282.78 Mn |
| Sep 30, 2023 | 349.06 Mn |
| Jun 30, 2023 | 371.85 Mn |
| Mar 31, 2023 | 417.88 Mn |
| Dec 31, 2022 | 433.26 Mn |
| Sep 30, 2022 | 480.48 Mn |
| Jun 30, 2022 | 537.56 Mn |
| Mar 31, 2022 | 611.70 Mn |
| Dec 31, 2021 | 670.17 Mn |
| Dec 31, 2020 | 367.73 Mn |